Send the following on WhatsApp
Continue to ChatThe safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation - https://avesis.istanbul.edu.tr/yayin/0c3ad19c-21b5-48fd-a03e-068dcd0c41b0/the-safety-of-pegylated-interferon-alpha-2b-in-the-treatment-of-chronic-hepatitis-b-predictive-factors-for-dose-reduction-and-treatment-discontinuation